Mariam F. Eskander
The Ohio State University, Rutgers Cancer Institute of New Jersey
Papers
3
Total Citations
61
H-Index
2
About
Dr. Mariam F. Eskander is a leading surgical oncologist whose research focuses on refining patient selection and outcomes in minimally invasive and robotic hepatopancreatobiliary (HPB) surgery. Her major contributions center on evidence-based evaluation of complex pancreatic and hepatic procedures. Her landmark 2016 study, with 41 citations, provided a nationwide assessment of patient selection for minimally invasive distal pancreatectomy (MIDP), identifying actual risk factors for adverse outcomes compared to open surgery—a critical step in standardizing surgical decision-making. Dr. Eskander has also advanced the field by investigating strategies to mitigate the steep learning curve for robotic pancreaticoduodenectomy, as detailed in her 2021 work (18 citations), demonstrating that comprehensive training protocols can safely expand access to robotic techniques. Her 2022 analysis on the value of the robotic platform for major hepatectomies further underscores her commitment to quantifying the benefits of surgical innovation. Through her rigorous, data-driven approach, Dr. Eskander has shaped national guidelines and improved perioperative care, making her a pivotal figure in the evolution of HPB surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3What Is the Value of the Robotic Platform for Major Hepatectomies?2 citations · 2022